AxoGen Announces Proposed Public Offering Of Common Stock

AxoGen, Inc., a global leader in innovative surgical solutions for peripheral nerve injuries, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.